Saturday, August 27, 2016

Profound Medical names Arun Menawat as CEO

Profound Medical names Arun Menawat as CEO

August 15, 2016 by · Leave a Comment 

Tweet Profound Medical (TSX-V:PRN) appointed Arun Menawat as its new CEO.  Steven Plymale, the company’s current CEO, will transition to President and COO. Dr. Menawat has been a member of Profound’s board since October 2014. Most recently, he was president and CEO of Novadaq Technologies, which pioneered the field of fluorescence imaging in the operating […]

Novadaq Q2 revenue climbs 34%

Novadaq Q2 revenue climbs 34%

July 27, 2016 by · Leave a Comment 

Tweet Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) reported revenue of $20.1-million in the second quarter, an increase of 34% from $15.1-million a year ago. Total direct sales in the latest quarter increased by $4.4-million, or 37%, and total partnered/international sales rose by $600,000, or 21%, compared with the same period last year. The company estimates that the number […]

Novadaq announces CEO change

Novadaq announces CEO change

July 6, 2016 by · Leave a Comment 

Tweet Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) has appointed Dr. Rick Mangat as president and CEO, succeeding Arun Menawat, who has resigned as president, CEO and chairman, to pursue new opportunities and interests. In addition, Bill MacKinnon, former CEO of KPMG Canada and head of the Novadaq’s audit committee, has been appointed chairman. Dr. Mangat is a […]

Novadaq posts 52% jump in Q1 revenue

Novadaq posts 52% jump in Q1 revenue

April 27, 2016 by · Leave a Comment 

Tweet Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) has reported first quarter revenue of $17.7-million, up 52%, from $11.7-million a year ago. Total direct sales in the quarter rose by $6.1-million, or 71%, and total partnered/international sales declined by $100,000, compared with the year earlier period. The company estimates that the number of procedures performed using SPY technology systems […]

Novadaq posts 54% jump in Q4 revenue

Novadaq posts 54% jump in Q4 revenue

February 18, 2016 by · Leave a Comment 

Tweet Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) has reported revenue of $20-million for the final quarter of 2015, up 54% from $13-million in the year earlier quarter, and up 18% from the third quarter of 2015. Product sales increased by $9.3-million, or 95%, primarily due to an 89% increase in capital sales and a 107% increase in […]

In conversation with Charles Haff

In conversation with Charles Haff

February 16, 2016 by · Leave a Comment 

Tweet As a senior research analyst at Craig-Hallum Capital Group, Charles Haff covers medical devices and ancillary healthcare services. Previously, he covered medical devices at Dougherty & Company and was a buy side healthcare analyst for 12 years at Thrivent Asset Management, a Minneapolis insurance company, Security Global Investors and JPMorgan Asset Management, where he […]

Novadaq Q4 revenue to jump about 54%

Novadaq Q4 revenue to jump about 54%

January 12, 2016 by · Leave a Comment 

Tweet Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) has released preliminary unaudited revenue for the fourth quarter of 2015 of approximately $20-million, reflecting increases of about 54% from $13-million in the 2014 fourth quarter and 18% sequentially over $17-million in the third quarter last year. For all of 2015, the company anticipates total revenues to be approximately $63.8-million, […]

JMP resumes coverage of Novadaq at outperform

JMP resumes coverage of Novadaq at outperform

January 6, 2016 by · Leave a Comment 

Tweet JMP Securities has resumed coverage of Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) with a “market outperform” rating and $16 price target. The stock closed at $13.50 on Tuesday. “Novadaq was once highly regarded within the small cap MedTech world, but its shares were driven down from historical highs by what we believe were overblown concerns around […]

Wedbush ups Novadaq price target to $17

Wedbush ups Novadaq price target to $17

November 12, 2015 by · Leave a Comment 

Tweet Wedbush Securities has raised its price target for “outperform-rated” Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) to $17 from $15. The stock finished at $11.16 on Wednesday. “Novadaq is the leader in the rapidly growing intraoperative fluorescence imaging market, and we believe the company’s extensive research and development in this field, plus cumulative clinical/commercial experience, should keep […]

Novadaq Q3 revenue climbs 40%

Novadaq Q3 revenue climbs 40%

October 28, 2015 by · Leave a Comment 

Tweet Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) reported revenue of $17-million for the third quarter this year, an increase of 40% from $12.1-million a year ago. Product sales increased by $5.2-million, or 47%, primarily due to a 53% increase in capital sales and a 38% increase in recurring revenue. The company estimates that the number of procedures […]

Next Page »

Email Newsletters with Constant Contact
Google+